Article |
Address correspondence to J. Klumperman, Cell Microscopy Center, Department of Cell Biology, University Medical Center Utrecht, AZU RM G02.525, Heidelberglaan 100, 3584CX Utrecht, Netherlands. Tel.: 31-30-250-6550. Fax: 31-30-254-1797. email: j.klumperman{at}lab.azu.nl
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key Words: AP-3 adaptor protein; TGN; endosomes; immuno-EM; clathrin
Abbreviations used in this paper: AP, adaptor protein; ASGPR, asialoglycoprotein receptor; CI-MPR, cation-independent mannose 6-phosphate receptor; EE, early endosome; LAMP, lysosome-associated membrane protein; NRK, normal rat kidney; Tf, transferrin; Tf-biotin, biotinylated transferrin; TfR, transferrin receptor.
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Although the AP-3 adaptor complex was identified relatively recently, a considerable amount of functional information has already been acquired, thanks to the availability of naturally occurring mutants. Loss of functional AP-3 complex leads to defects in the function of lysosomes and lysosome-related organelles. The most obvious trafficking defect in AP-3deficient cells is that integral lysosomal membrane proteins (also known as lysosomal glycoproteins), including lysosome-associated membrane proteins (LAMPs) 1 and 2, LIMP-2, CD63, and CD1, show increased trafficking via the plasma membrane (Dell'Angelica et al., 1999; Rous et al., 2002; Sugita et al., 2002). Nevertheless, their steady-state distribution is still mainly lysosomal. Mannose 6-phosphate receptorbased transport of soluble lysosomal enzymes and cycling of the transferrin receptor (TfR) between the plasma membrane and endosomes are independent of AP-3 function (Le Borgne et al., 1998; Dell'Angelica et al., 1999).
Despite the accumulating evidence implicating AP-3 in the intracellular transport of lysosomal membrane proteins, the transport step that is mediated by AP-3 has remained unclear. In yeast, like in mammalian cells, AP-3 deletion leads to the missorting of the vacuolar membrane proteins alkaline phosphate and Vam3p, but does not affect the trafficking of Vps10p, the receptor for the soluble hydrolase carboxypeptidase Y (Cowles et al., 1997; Stepp et al., 1997). By contrast, yeast VPS mutants are still able to sort vacuolar membrane proteins to the vacuole. Hence, it was proposed that in yeast, AP-3 mediates a direct pathway for vacuolar membrane proteins from the TGN to the vacuole (Odorizzi et al., 1998). In mammalian cells, immunofluorescence localization experiments of the AP-3 complex have revealed concentrated staining in the perinuclear region, partially overlapping with markers of the TGN, but also significant staining out in the cell periphery, partially colocalizing with endocytic markers such as TfR (Simpson et al., 1996, 1997; Dell'Angelica et al., 1997, 1999). The degree of overlap with either TGN or endosomal markers varied considerably between these experiments. EM localization analyses also indicated a dual localization of the AP-3 complex on the TGN, as well as on endosomes (Simpson et al., 1996; Dell'Angelica et al., 1998).
At present, two (not mutually exclusive) models have been proposed to explain the role of the AP-3 complex in lysosomal membrane protein trafficking in mammalian cells (for review see Starcevic et al., 2002). In the first model, as in yeast, AP-3 is proposed to be responsible for recruiting lysosomal membrane proteins into a direct transport pathway from the TGN to endosomes/lysosomes. Lack of AP-3 function would then result in increased amounts of newly synthesized proteins traveling from the TGN via the constitutive pathway to the plasma membrane, from where it would be internalized by AP-2dependent endocytosis and subsequently transported to the lysosomes. The second model proposes that AP-3 functions at an early endosomal compartment in which lysosomal membrane proteins must be segregated from other membrane proteins that recycle back to the plasma membrane. Lack of functional AP-3 would then lead to a buildup on the plasma membrane and in the recycling system.
The role of clathrin in AP-3 function has also remained controversial. Two isoforms of the AP-3 ß subunit are known, the ubiquitous ß3A and the neuro (endocrine)-specific ß3B, both of which contain a clathrin consensus-binding motif (Dell'Angelica et al., 1998; ter Haar et al., 2000). Biochemical analyses have shown that AP-3 can bind and recruit clathrin in vitro onto synthetic liposomes (Dell'Angelica et al., 1998; Drake et al., 2000). However, unlike AP-1 and AP-2, the AP-3 complex is not enriched in purified clathrin-coated vesicles (Simpson et al., 1996; unpublished data), and genetic and biochemical evidence suggest that the AP-3 complex does not require clathrin for function in vivo (Vowels and Payne, 1998; Wettey et al., 2002). Moreover, AP-3deficient mammalian cells were shown to be rescued almost as well by a ß3A construct lacking the consensus clathrin-binding site as by the wild-type construct, suggesting that clathrin binding to the ß3A subunit of the AP-3 is not required for AP-3 function (Peden et al., 2002). Immuno-colocalization analyses of clathrin and AP-3 have also produced conflicting results (Simpson et al., 1996; Dell'Angelica et al., 1998; Peden et al., 2002). Thus, whether or not clathrin is required for AP-3 function still remains unclear.
To address these key questions on AP-3 function, we have generated an mAb against the subunit of the AP-3 complex, and have used this antibody to localize AP-3 by immuno-EM. This approach offers the unique possibility of localizing AP-3 in direct comparison to lysosomal membrane proteins, as well as with other cargo and coat proteins, at a resolution sufficient to define small membrane microdomains involved in protein sorting. Our results provide evidence for the function of the AP-3 complex in the trafficking of lysosomal membrane proteins from endosomes, whereas no support for a role at the TGN was found. Unexpectedly, our data indicate that the endosomal AP-3 pathway arises from early endosome (EE)associated tubules rather than the endosomal vacuole, implicating tubular endosomes also involved in protein recycling as an important intermediate station in lysosomal membrane protein traffic to the lysosomes.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Immuno-EM localization of the AP-3 complex on EE-associated tubules
To investigate the localization of the AP-3 adaptor complex in subcellular detail, ultrathin cryosections were prepared from HepG2 and normal rat kidney (NRK) cells, and were immunogold labeled with the different anti--subunit mAbs. Significant specific immunogold labeling was obtained with several anti-AP-3 monoclonals, but SA4 was selected for this work as it gave the highest labeling efficiency, especially in cells fixed only with formaldehyde. Although we obtained a similar staining pattern for AP-3 in both cell lines, we concentrated on HepG2 cells because they exhibited stronger staining.
First, we addressed whether AP-3 resides on the TGN and/or on endosome-associated membranes. The tubular membrane network within a distance of 500 nm from the trans-most cisternae of a Golgi stack was considered as TGN (Geuze et al., 1985). These membranes are enriched in cation-independent mannose 6-phosphate receptor (CI-MPR; Fig. 1) and TGN46 (unpublished data), and show clathrin-coated and AP-1coated buds at their cytoplasmic surface (Fig. 1 A) that mediate the exit of CI-MPR from the TGN to the endosomes (Klumperman et al., 1993; Doray et al., 2002; Waguri et al., 2003). The average diameter of the CI-MPR and AP-1positive buds on the TGN was 77 nm (n = 42). No significant AP-3 labeling was found in these TGN profiles (Fig. 1, BD).
|
|
|
|
|
|
|
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
First, we set out to address to what compartment (or compartments) the AP-3 complex localizes in mammalian cells. In HepG2 cells, AP-3 was typically found on budding profiles emerging from endosomal tubules containing internalized Tf-biotin and ASGPR, two classical markers of the endosomal recycling pathway (Dautry-Varsat et al., 1983; Geuze et al., 1983; Klausner et al., 1983; Hopkins et al., 1994), and CI-MPR, which recycles between endosomes and the TGN (Kornfeld and Mellman, 1989). In addition, AP-3bearing tubules contained the lysosomal proteins LAMP-1 and LAMP-2 and displayed distinct, small-sized AP-1positive buds. AP-1 on endosomal tubules has been implicated in retrograde transport of MPR46 and Shiga toxin B subunit to the TGN (Mallard et al., 1998; Meyer et al., 2000), as well as recycling of internalized Tf (Mallard et al., 1998; van Dam and Stoorvogel, 2002). The presence of distinct types of recycling proteins and the association of multiple adaptor complexes suggest that from the AP-3containing tubular endosomes, proteins are sorted to distinct destinations in the cell. Therefore, the AP-3positive compartment is best referred to as tubular sorting endosome. A point of future interest will be to define the physical and functional boundaries between the tubular sorting endosome, vacuolar sorting endosomes, and tubular recycling endosomes.
Our quantitative analyses revealed that of the different types of cargo proteins present in the tubular sorting endosomes, only LAMP-1 and LAMP-2 were concentrated in the AP-3positive buds and associated vesicular profiles (Table I). By contrast, ASGPR and CI-MPR were equally distributed over the AP-3bearing and nonlabeled regions of the endosomal tubules. These findings imply that AP-3 on tubular sorting endosomes mediates an exit specific for lysosomal membrane proteins. Lysosomal membrane proteins may reach EEs via a direct pathway from the TGN or by following the constitutive secretory pathway to the cell surface and subsequent endocytosis (for review see Peters and von Figura, 1994; Hunziker and Geuze, 1996; Rouille et al., 2000). In rat hepatocytes, 45% of newly synthesized LAMP-2 and at least 25% of LAMP-1 passes through EEs before it reaches later compartments (Akasaki et al., 1995, 1996). A first possible pathway to the lysosome is then by incorporation into the intra-endosomal vesicles that form by inward budding of the limiting membrane, and this leads to the formation of multivesicular bodies (reviewed by Geuze, 1998). Sorting into intra-endosomal vesicles is an active, signal-mediated event, whereas recycling from EEs back to the cell surface can occur by default (Dunn et al., 1989; Jing et al., 1990; Mayor et al., 1993; Verges et al., 1999; Sachse et al., 2002). Lysosomal membrane proteins that are not sorted into the intra-endosomal vesicles will enter the tubular sorting endosomes. Our data suggest that from here a second, AP-3mediated sorting step to the lysosomes originates (see Fig. 8 for a model). As suggested previously (Dell'Angelica et al., 1999; Starcevic et al., 2002), the model in Fig. 8 also accounts for the increased transport of lysosomal proteins via the plasma membrane in AP-3deficient cells. Specifically, if AP-3 deficiency impairs transport from tubular sorting endosomes to lysosomes, it will lead to an increased incorporation of lysosomal membrane proteins into the default recycling pathway to the plasma membrane. Indeed, this was what we observed when we compared the level of recycling of endocytosed LAMP-1 and CD63 to the plasma membrane in AP-3deficient and rescued fibroblasts, providing additional strong evidence that AP-3 acts on an endosomal compartment. Consistent with previous papers (Le Borgne et al., 1998; Dell'Angelica et al., 1999), recycling of the TfR was unaffected in the AP-3deficient cells.
|
A role for AP-3 in lysosomal membrane protein traffic from tubular sorting endosomes is in agreement with previous immuno-EM data in PC12 and A431 cells (Dell'Angelica et al., 1998), and with the recent observation that in AP-3deficient cytotoxic T-lymphocytes, tubular endosomes elongate (Clark et al., 2003). Our observations are in contrast to a previous immuno-EM experiment in NRK cells by Simpson et al. (1996), showing that AP-3 labeling is mainly associated with the TGN. However, some of the localization experiments of Simpson et al. (1996) were done in the presence of GTPS, which can lead to the mislocalization of coat complexes (Seaman et al., 1993). By in vitro recruitment experiments in mocha cells in the presence of GTP
S, it was found that the AP-3 complex indeed distributes to a more perinuclear location than normal (unpublished data). We defined the TGN as the membrane network within
500 nm of the trans-side of the Golgi stack (Geuze et al., 1985). Our quantitations in rescued mocha cells revealed that 4% of total AP-3 label was found on membranes that by this definition were classified as TGN. 41% of the AP-3 label was found on tubulo-vesicular membranes associated with endosomes, whereas 40% of AP-3 label was not clearly associated with either endosomes or TGN (indicated as cytoplasmic). The majority of the cytoplasmic membranes is probably of endosomal origin, but we cannot exclude that they include peripheral TGN profiles as well (Puertollano et al., 2003; Waguri et al., 2003). Therefore, it remains possible that AP-3 does play a minor role in the trafficking of cargo molecules from the TGN, as was also suggested by others (Nishimura et al., 2002; Rous et al., 2002).
Another issue we addressed was the potential interaction of the AP-3 complex with clathrin. The association of AP-3 with clathrin has been shown previously (Dell'Angelica et al., 1998), but we provide here the first quantitative analysis in direct comparison with a well-known clathrin-binding adaptor, AP-1. We found in HepG2 cells 46% of AP-3positive membranes, and 91% of AP-1positive membranes were coated for clathrin as well. A previous work in neuroendocrine PC12 cells revealed that 65% of the AP-3positive membranes labeled for clathrin (Dell'Angelica et al., 1998), which is possibly explained by the fact that in these cells, AP-3 is involved in clathrin-dependent formation of synaptic vesicles from endosomes (Faundez et al., 1998). Together, the data in PC12 and HepG2 cells indicate that AP-3 uses clathrin in vivo, but that at steady state its association with clathrin is significantly lower than that of AP-1. Possibly, the interaction between AP-3 and clathrin is weaker than that found with the other adaptor complexes. This would also explain why the AP-3 complex is not present in clathrin-coated vesicle preparations and why clathrin is not readily immunoprecipitated with antibodies against AP-3 (Simpson et al., 1996; unpublished data). Alternatively or additionally, the assembly of an AP-3 clathrin coat may be a relatively slow process, resulting in lower steady-state levels of association. A third possible explanation is that clathrin might play a facilitating rather than obligatory role. Clearly, further analyses are required to distinguish between these possibilities.
![]() |
Materials and methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Flow cytometry
A quantitative assay for AP-3dependent sorting was used as described by Peden et al. (2002), with the modifications listed below. Cells were trypsinized, washed in complete medium, and incubated with Alexa® 488conjugated anti-LAMP-1 and anti-CD63 antibodies (2 µg/ml) for 30 min at 4°C. After shifting to 37°C for various times, the antibody binding was stopped by pelleting the cells and resuspending them in 3% formaldehyde. To determine the amount of recycling of LAMP-1, CD63, and TfR, cells were allowed to internalize labeled antibodies for 20 min, after which excess antibodies were washed away with ice-cold DME. The cells were then incubated with 24 µg/ml quenching antibody (anti-Alexa® 488; Molecular Probes, Inc.) in DME at 37°C for various times. To ensure complete quenching, the cells were placed on ice for 30 min before being fixed in 3% formaldehyde. The cells were analyzed using a flow cytometer (Epics-Xl; Beckman Coulter).
Retroviral infections
The AP-3 -subunitdeficient mocha cell line (CRL-2709; American Type Culture Collection), previously described by Peden et al. (2002), was infected with virus expressing human CD63, followed by infection with the wild-type
subunit of the AP-3 complex or empty virus as described by Swift et al. (1999). The virus used was a version of pBMN modified such that the hygromycin selectable marker was expressed on the same transcript as the
or CD63 messages. Infected cells were selected in 200 µg/ml hygromycin B.
Internalization of Tf-biotin and BSA-gold
Tf-biotin was obtained from Sigma-Aldrich and was iron saturated as described previously (Stoorvogel et al., 1987). HepG2 cells cultured in 6-cm-diam dishes were preincubated in MEM plus 0.1% BSA in a CO2 incubator at 37°C, and then 20 µg/ml Tf-biotin was added and allowed to internalize for 20 min. Cells were rinsed twice with MEM containing 0.1% BSA at 4°C and fixed overnight in a final concentration of 4% formaldehyde in 0.1 M phosphate buffer, pH 7.4. BSA conjugated to 5 nm colloidal gold (final OD of 5 at 520 nm) after overnight dialysis with serum-free media was similarly used to mark the endocytic pathway, except the internalization was for 60 min in 1.5 ml MEM containing 1% FCS and 100 µl BSA 5-nm gold.
Immuno-EM
Cells were fixed by adding 4% freshly prepared formaldehyde in 0.1 M phosphate buffer, pH 7.4, to an equal volume of culture medium for 10 min, followed by post-fixation in 4% formaldehyde without medium, and were stored at 4°C. Glutaraldehyde was found to strongly reduce the AP-3 labeling. Processing of cells for ultrathin cryosectioning and immunolabeling according to the protein Agold method was done as described previously (Slot et al., 1991; Liou et al., 1996).
To measure the diameter of AP-3 and AP-1labeled budding profiles, pictures of positively labeled membranes were randomly taken at a magnification of 30,000 in the EM and used at an end magnification of 81,000. The diameter of a labeled bud was measured with a ruler, after which the data were recalculated to nanometers. For these countings, we did not include vesicular profiles nor the long AP-1/clathrin stretches found on the TGN. We focused on buds clearly connected to TGN or endosomes.
To measure the degree of colocalization of AP-3 and AP-1 with clathrin, HepG2 cells were double labeled for AP-3 (15-nm gold) and AP-1 (10-nm gold). By moving randomly through the grid, for each AP-3 or AP-1representing gold particle it was established whether it was present on a membrane bearing a visible clathrin coat. In total, 380 and 341 gold particles were counted for AP-3 and AP-1, respectively, in three independent experiments.
The labeling densities of CI-MPR, ASGPR, LAMP-1, and LAMP-2 were established in series of double-labeling experiments in which AP-3 was always used in the first step. AP-3positive membranes were selected in the EM and photographed only when they were also positive for the marker protein under analysis. Per marker protein, at least 50 pictures were taken at a magnification of 30,000 and were analyzed at an end magnification of 81,000. The pictures were overlaid with a transparent 5-mm spaced line lattice. The number of gold particles present on AP-3positive and AP-3negative regions of the compartments were counted, as well as the number of intersections of the distinct membrane domains with the 5-mm line lattice overlay, to give a measure of membrane length (Weibel, 1979). The labeling density was then expressed as number of gold particles per intersection, which reflects the concentration of a given protein in a membrane domain.
The relative distribution of AP-3 in rescued mocha cells was assessed by analyzing 500 ad random sampled cell profiles from two distinct grids. All gold particles that were no further than 25 nm from a membrane were ascribed to the compartment on which they were found. This resulted in a total of 555 gold particles over the relevant intracellular compartments. A similar analysis in mocha cells (prepared and labeled in the same experiment as the rescued mochas) yielded 74 gold particles, representing nonspecific background. After subtracting the background label over the distinct compartments from the specific label, the percentage of total label over a given compartment in rescued mocha cells was calculated (Table II). All tubulo-vesicular membranes within 200 nm from an endosomal vacuole were designated as being endosome associated, whereas membranes within 500 nm of the trans-side of a Golgi complex were designated TGN. Tubulo-vesicular membranes that in the plane of the section were not associated with Golgi or endosomes were designated as cytoplasmic. All pictures were taken on a transmission electron microscope (model 1010; JEOL USA, Inc.).
Immunofluorescence
Cells were cultured on multiwell slides (ICN Biomedicals), fixed for 15 min with 3% PFA in PBS, quenched for 10 min with 0.1 M glycine in PBS, permeabilized with 0.4% saponin in PBS for 10 min, and were then stained with the primary antibody for 30 min. After incubation with secondary antibody conjugated to Alexa® 488 or 594 for 20 min, coverslips were mounted onto the cells with Vectashield® (Vector Laboratories). Images were acquired using a microscope (Axiovert 200; Carl Zeiss MicroImaging, Inc.) fitted with a Plan-Apochromat 1.4 NA 63x objective, a camera (AxioCam; Carl Zeiss MicroImaging, Inc.), and a Quad pass filter set (Chroma Technology Corp.), all controlled by AxioVison 3.1 software (Carl Zeiss MicroImaging, Inc.). The brightness and contrast of acquired images was adjusted using Adobe Photoshop® v6.0.
Online supplemental material
Fig. S1 shows the characterization of mAb SA4 against the subunit of AP-3 that was used in this work. Fig. S2 shows the fluorescence staining of LAMP-1 and CD63 in mock-transfected and rescued mocha cells. Fig. S3 shows the colocalization of AP-3 and LAMP-1 in endosomal tubules of rescued mocha cells. Fig. S4 and Fig. S5 show the triplicates of the antibody binding and recycling assays described in Fig. 6 and Fig. 7, respectively. Online supplemental material available at http://www.jcb.org/cgi/content/full/jcb.200311064/DC1.
![]() |
Acknowledgments |
---|
Initially, A.A. Peden was supported by a grant from the Wellcome trust.
Submitted: 18 November 2003
Accepted: 13 February 2004
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Akasaki, K., M. Fukuzawa, H. Kinoshita, K. Furuno, and H. Tsuji. 1993. Cycling of two endogenous lysosomal membrane proteins, lamp-2 and acid phosphatase, between the cell surface and lysosomes in cultured rat hepatocytes. J. Biochem. (Tokyo). 114:598604.
Akasaki, K., A. Michihara, K. Mibuka, Y. Fujiwara, and H. Tsuji. 1995. Biosynthetic transport of a major lysosomal membrane glycoprotein, lamp-1: convergence of biosynthetic and endocytic pathways occurs at three distinctive points. Exp. Cell Res. 220:464473.[CrossRef][Medline]
Akasaki, K., A. Michihara, Y. Fujiwara, K. Mibuka, and H. Tsuji. 1996. Biosynthetic transport of a major lysosome-associated membrane glycoprotein 2, lamp-2: a significant fraction of newly synthesized lamp-2 is delivered to lysosomes by way of early endosomes. J. Biochem. (Tokyo). 120:10881094.
Bock, J.B., J. Klumperman, S. Davanger, and R.H. Scheller. 1997. Syntaxin 6 functions in trans-Golgi network vesicle trafficking. Mol. Biol. Cell. 8:12611271.[Abstract]
Clark, R.H., J.C. Stinchcombe, A. Day, E. Blott, S. Booth, G. Bossi, T. Hamblin, E.G. Davies, and G.M. Griffiths. 2003. Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapse. Nat. Immunol. 4:11111120.[CrossRef][Medline]
Cowles, C.R., G. Odorizzi, G.S. Payne, and S.D. Emr. 1997. The AP-3 adaptor complex is essential for cargo-selective transport to the yeast vacuole. Cell. 91:109118.[CrossRef][Medline]
Dautry-Varsat, A., A. Ciechanover, and H.F. Lodish. 1983. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA. 80:22582262.[Abstract]
Dell'Angelica, E.C., H. Ohno, C.E. Ooi, E. Rabinovich, K.W. Roche, and J.S. Bonifacino. 1997. AP-3: an adaptor-like protein complex with ubiquitous expression. EMBO J. 16:917928.
Dell'Angelica, E.C., J. Klumperman, W. Stoorvogel, and J.S. Bonifacino. 1998. Association of the AP-3 adaptor complex with clathrin. Science. 280:431434.
Dell'Angelica, E.C., V. Shotelersuk, R.C. Aguilar, W.A. Gahl, and J.S. Bonifacino. 1999. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the ß3A-subunit of the AP-3 adaptor. Mol. Cell. 3:1121.[Medline]
Doray, B., P. Ghosh, J. Griffith, H.J. Geuze, and S. Kornfeld. 2002. Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network. Science. 297:17001703.
Drake, M.T., Y. Zhu, and S. Kornfeld. 2000. The assembly of AP-3 adaptor complex-containing clathrin-coated vesicles on synthetic liposomes. Mol. Biol. Cell. 11:37233736.
Dunn, K.W., T.E. McGraw, and F.R. Maxfield. 1989. Iterative fractionation of recycling receptors from lysosomally destined ligands in an early sorting endosome. J. Cell Biol. 109:33033314.[Abstract]
Faundez, V., J.T. Horng, and R.B. Kelly. 1998. A function for the AP3 coat complex in synaptic vesicle formation from endosomes. Cell. 93:423432.[Medline]
Geuze, H.J. 1998. The role of endosomes and lysosomes in MHC class II functioning. Immunol. Today. 19:282287.[CrossRef][Medline]
Geuze, H.J., J.W. Slot, G.J. Strous, H.F. Lodish, and A.L. Schwartz. 1983. Intracellular site of asialoglycoprotein receptor-ligand uncoupling: double-label immunoelectron microscopy during receptor-mediated endocytosis. Cell. 32:277287.[Medline]
Geuze, H.J., J.W. Slot, G.J. Strous, A. Hasilik, and K. von Figura. 1985. Possible pathways for lysosomal enzyme delivery. J. Cell Biol. 101:22532262.[Abstract]
Griffiths, G., R. Back, and M. Marsh. 1989. A quantitative analysis of the endocytic pathway in baby hamster kidney cells. J. Cell Biol. 109:27032720.[Abstract]
Harter, C., and I. Mellman. 1992. Transport of the lysosomal membrane glycoprotein lgp120 (lgpA) to lysosomes does not require appearance on the plasma membrane. J. Cell Biol. 117:311325.[Abstract]
Heuser, J.E., and J. Keen. 1988. Deep-etch visualization of proteins involved in clathrin assembly. J. Cell Biol. 107:877886.[Abstract]
Hopkins, C.R., A. Gibson, M. Shipman, D.K. Strickland, and I.S. Trowbridge. 1994. In migrating fibroblasts, recycling receptors are concentrated in narrow tubules in the pericentriolar area, and then routed to the plasma membrane of the leading lamella. J. Cell Biol. 125:12651274.[Abstract]
Hughes, E.N., and J.T. August. 1981. Characterization of plasma membrane proteins identified by monoclonal antibodies. J. Biol. Chem. 256:664671.
Hunziker, W., and H.J. Geuze. 1996. Intracellular trafficking of lysosomal membrane proteins. Bioessays. 18:379389.[Medline]
Jing, S.Q., T. Spencer, K. Miller, C. Hopkins, and I.S. Trowbridge. 1990. Role of the human transferrin receptor cytoplasmic domain in endocytosis: localization of a specific signal sequence for internalization. J. Cell Biol. 110:283294.[Abstract]
Klausner, R.D., G. Ashwell, J. van Renswoude, J.B. Harford, and K.R. Bridges. 1983. Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc. Natl. Acad. Sci. USA. 80:22632266.[Abstract]
Klumperman, J., A. Hille, T. Veenendaal, V. Oorschot, W. Stoorvogel, K. von Figura, and H.J. Geuze. 1993. Differences in the endosomal distributions of the two mannose 6-phosphate receptors. J. Cell Biol. 121:9971010.[Abstract]
Kornfeld, S., and I. Mellman. 1989. The biogenesis of lysosomes. Annu. Rev. Cell Biol. 5:483525.[CrossRef][Medline]
Le Borgne, R., A. Alconada, U. Bauer, and B. Hoflack. 1998. The mammalian AP-3 adaptor-like complex mediates the intracellular transport of lysosomal membrane glycoproteins. J. Biol. Chem. 273:2945129461.
Lesley, J., R. Hyman, R. Schulte, and J. Trotter. 1984. Expression of transferrin receptor on murine hematopoietic progenitors. Cell. Immunol. 83:1425.[Medline]
Liou, W., H.J. Geuze, and J.W. Slot. 1996. Improving structural integrity of cryosections for immunogold labeling. Histochem. Cell Biol. 106:4158.[CrossRef][Medline]
Lippincott-Schwartz, J., and D.M. Fambrough. 1987. Cycling of the integral membrane glycoprotein, LEP100, between plasma membrane and lysosomes: kinetic and morphological analysis. Cell. 49:669677.[Medline]
Mallard, F., C. Antony, D. Tenza, J. Salamero, B. Goud, and L. Johannes. 1998. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J. Cell Biol. 143:973990.
Marsh, M., G. Griffiths, G.E. Dean, I. Mellman, and A. Helenius. 1986. Three-dimensional structure of endosomes in BHK-21 cells. Proc. Natl. Acad. Sci. USA. 83:28992903.[Abstract]
Mayor, S., J.F. Presley, and F.R. Maxfield. 1993. Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk flow process. J. Cell Biol. 121:12571269.[Abstract]
Meyer, C., D. Zizioli, S. Lausmann, E.L. Eskelinen, J. Hamann, P. Saftig, K. von Figura, and P. Schu. 2000. µ1A adaptin-deficient mice: lethality, loss of AP-1 binding and rerouting of mannose 6-phosphate receptors. EMBO J. 19:21932203.
Nishimura, N., H. Plutner, K. Hahn, and W.E. Balch. 2002. The subunit of AP-3 is required for efficient transport of VSV-G from the trans-Golgi network to the cell surface. Proc. Natl. Acad. Sci. USA. 99:67556760.
Odorizzi, G., C.R. Cowles, and S.D. Emr. 1998. The AP-3 complex: a coat of many colours. Trends Cell Biol. 8:282288.[CrossRef][Medline]
Peden, A.A., R.E. Rudge, W.W. Lui, and M.S. Robinson. 2002. Assembly and function of AP-3 complexes in cells expressing mutant-subunits. J. Cell Biol. 156:327336.
Peters, C., and K. von Figura. 1994. Biogenesis of lysosomal membranes. FEBS Lett. 346:108114.[CrossRef][Medline]
Puertollano, R., N.N. van der Wel, L.E. Greene, E. Eisenberg, P.J. Peters, and J.S. Bonifacino. 2003. Morphology and dynamics of clathrin/GGA1-coated carriers budding from the trans-Golgi network. Mol. Biol. Cell. 14:15451557.[CrossRef][Medline]
Reusch, U., O. Bernhard, U. Koszinowski, and P. Schu. 2002. AP-1A and AP-3A lysosomal sorting functions. Traffic. 3:752761.[CrossRef][Medline]
Robinson, M.S., and J.S. Bonifacino. 2001. Adaptor-related proteins. Curr. Opin. Cell Biol. 13:444453.[CrossRef][Medline]
Rouille, Y., W. Rohn, and B. Hoflack. 2000. Targeting of lysosomal proteins. Semin. Cell Dev. Biol. 11:165171.[CrossRef][Medline]
Rous, B.A., B.J. Reaves, G. Ihrke, J.A. Briggs, S.R. Gray, D.J. Stephens, G. Banting, and J.P. Luzio. 2002. Role of adaptor complex AP-3 in targeting wild-type and mutated CD63 to lysosomes. Mol. Biol. Cell. 13:10711082.
Sachse, M., S. Urbe, V. Oorschot, G.J. Strous, and J. Klumperman. 2002. Bilayered clathrin coats on endosomal vacuoles are involved in protein sorting toward lysosomes. Mol. Biol. Cell. 13:13131328.
Seaman, M.N., C.L. Ball, and M.S. Robinson. 1993. Targeting and mistargeting of plasma membrane adaptors in vitro. J. Cell Biol. 123:10931105.[Abstract]
Simpson, F., N.A. Bright, M.A. West, L.S. Newman, R.B. Darnell, and M.S. Robinson. 1996. A novel adaptor-related protein complex. J. Cell Biol. 133:749760.[Abstract]
Simpson, F., A.A. Peden, L. Christopoulou, and M.S. Robinson. 1997. Characterization of the adaptor-related protein complex, AP-3. J. Cell Biol. 137:835845.
Slot, J.W., H.J. Geuze, S. Gigengack, G.E. Lienhard, and D.E. James. 1991. Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J. Cell Biol. 113:123135.[Abstract]
Starcevic, M., R. Nazarian, and E.C. Dell'Angelica. 2002. The molecular machinery for the biogenesis of lysosome-related organelles: lessons from Hermansky-Pudlak syndrome. Semin. Cell Dev. Biol. 13:271278.[CrossRef][Medline]
Stepp, J.D., K. Huang, and S.K. Lemmon. 1997. The yeast adaptor protein complex, AP-3, is essential for the efficient delivery of alkaline phosphatase by the alternate pathway to the vacuole. J. Cell Biol. 139:17611774.
Stoorvogel, W., H.J. Geuze, and G.J. Strous. 1987. Sorting of endocytosed transferrin and asialoglycoprotein occurs immediately after internalization in HepG2 cells. J. Cell Biol. 104:12611268.[Abstract]
Sugita, M., X. Cao, G.F. Watts, R.A. Rogers, J.S. Bonifacino, and M.B. Brenner. 2002. Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity. 16:697706.[Medline]
Swift, S., J.B. Lorens, P. Achacoso, and G.P. Nolan. 1999. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. John Wiley & Sons Inc., New York. Suppl. 31.
ter Haar, E., S.C. Harrison, and T. Kirchhausen. 2000. Peptide-in-groove interactions link target proteins to the ß-propeller of clathrin. Proc. Natl. Acad. Sci. USA. 97:10961100.
van Dam, E.M., and W. Stoorvogel. 2002. Dynamin-dependent transferrin receptor recycling by endosome-derived clathrin-coated vesicles. Mol. Biol. Cell. 13:169182.
Verges, M., R.J. Havel, and K.E. Mostov. 1999. A tubular endosomal fraction from rat liver: biochemical evidence of receptor sorting by default. Proc. Natl. Acad. Sci. USA. 96:1014610151.
Vowels, J.J., and G.S. Payne. 1998. A dileucine-like sorting signal directs transport into an AP-3-dependent, clathrin-independent pathway to the yeast vacuole. EMBO J. 17:24822493.
Waguri, S., F. Dewitte, R. Le Borgne, Y. Rouille, Y. Uchiyama, J.F. Dubremetz, and B. Hoflack. 2003. Visualization of TGN to endosome trafficking through fluorescently labeled MPR and AP-1 in living cells. Mol. Biol. Cell. 14:142155.
Weibel, E.R. 1979. Stereological Methods: Practical Methods for Biological Morphometry. Vol. 1. Academic Press, London/New York. 415 pp.
Wettey, F.R., S.F. Hawkins, A. Stewart, J.P. Luzio, J.C. Howard, and A.P. Jackson. 2002. Controlled elimination of clathrin heavy-chain expression in DT40 lymphocytes. Science. 297:15211525.